Expo News Today — September 21, 2026

Global markets are navigating a mix of corporate updates and geopolitical developments. In the pharmaceutical space, Novo Nordisk's stock is under pressure as the company behind popular weight-loss drug Ozempic outlines its goals for 2030, sparking investor scrutiny of its long-term strategy. Meanwhile, a shutdown of the Saudi East-West pipeline is set to have implications for Asia's major crude importers, highlighting the ongoing impact of geopolitical events on global commodity flows.

Beyond these market-moving headlines, individual investors are also grappling with decisions about how to manage their wealth. A reader with a substantial nest egg is seeking advice on how to make the most of their $10 million, underscoring the challenges of managing significant assets in a responsible and impactful way. In a separate story, Williams-Sonoma has defied expectations in a sluggish housing market, winning over Wall Street with its performance and demonstrating that some companies are able to thrive even in challenging conditions. These disparate stories highlight the complex and multifaceted nature of global markets and the varied challenges and opportunities that investors face.

Today's signal:
• Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals (marketwatch.com)
• Here's what the Saudi East-West pipeline shutdown means for Asia's biggest crude importers (cnbc.com)
• ‘My main goal is to help people’: I’m single, 74, with $10 million burning a hole in my pocket. What should I do? (marketwatch.com)
• Williams-Sonoma's stock has soared in a sluggish housing market. Here's how it won over Wall Street (cnbc.com)